临床试验/IRCT20210519051345N31

IRCT20210519051345N31招募中Unknown

Bioequivalence study of Empagliflozin 5/Metformin 500 mg tablet in healthy male volunteers using crossover design

Tabriz University of Medical Sciences0 个研究点目标入组 24 人开始时间: 待定最近更新: 2023年7月25日

试验速览

阶段: Unknown
状态: 招募中
发起方: Tabriz University of Medical Sciences
入组人数: 24

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 years 至 59 years（—）
性别: All

入选标准

•General Health (in terms of Liver, Heart and Kidney)
•Age between 18 to 59 years

排除标准

•History of cardiovascular disease, liver and kidney disease
•Alcohol and drug addiction
•History of drug allergy

研究者

发起方

Tabriz University of Medical Sciences

相似试验

Bioequivalence study of Empagliflozin 5 mg/ Metformin 1000 mg film coated tablet manufactured by Modava Pharmaceutical Company

IRCT20130313012810N22Modava Pharmaceutical Company24

Bioequivalence study of Empagliflozin/Metformin12.5/1000 mgThis study is performed on healthy volunteers and drug concentration in plasma is determined..

IRCT20200105046010N93Faran Pharmed company24

Bioequivalence study of Empagliflozin Metformin 12.5-1000 mgBioequivalence study of Empagliflozin Metformin 12.5-1000 mg (Tehran Chemie Pharmaceutical Company) versus Synjiardy(Boehringer Ingelheim) Tablet after single oral dosing in healthy volunteers.

IRCT20220111053692N17Tehran Chemie Pharmaceutical Company24

Comparison of the effect of Metformin and Empagliflozin in treatment of prediabetic patients.Prediabetes.Abnormal glucose tolerance testR73.0

IRCT20210926052602N1Kashan University of Medical Sciences100

Bioequivalence Study of Empagliflozin/Metformin 5/500 mgThis study is performed on healthy volunteers and drug concentration in plasma is determined..

IRCT20200105046010N95Kharazmi Pharmacy24